lung cancer screening by LDCT low-dose computerized tomography LDCT lung cancer screening economic evaluation cost-utility analysis CUA feasibility readiness
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. a lung cancer patient who has been diagnosed and classified by stage of disease (early or late) and health (Progression disease, progression-free disease-free or recurrent/relapse) 2. high-risk population for lung cancer who had LDCT for lung cancer screening and have a negative or false positive result
Exclusion criteria
Exclusion criteria: 1. Individuals with conditions that prevent them from providing reliable information, such as acute confusion, severe psychiatric disorders, or dementia. 2. Patients with comorbid conditions that significantly affect daily functioning and may influence the assessment of quality of life, such as severe heart failure (NYHA class III to IV) or end-stage chronic kidney disease requiring dialysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality-adjusted life year (QALY) In period of the study for 1 year cycle model EQ-5D-5L,Indirect medical cost In period of the study Interview,Direct non-medical cost In period of the study Interview | — |
Secondary
| Measure | Time frame |
|---|---|
| low-dose computed tomography service readiness In period of the study Interview,low-dose computed tomography availability In period of the study questionnaire | — |
Countries
Thailand
Contacts
Siriraj Health Policy